PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Suicide and Life-Threatening Behavior

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Suicide and Life-Threatening Behavior has 1 tracked paper indexed in Blossom (2021) from 4 authors, most often covering Ketamine, across Suicidality and Depressive Disorders.

Published Papers

Open Accessmeta

Clinical trials for rapid changes in suicidal ideation: Lessons from ketamine

This review synthesises methodological lessons from ketamine studies to recommend how clinical trials can be adapted to evaluate rapid reductions in suicidal ideation, emphasising rapid outcome measurement and embedding psychological and neurobiological markers. The authors propose these approaches as a blueprint for testing rapid‑acting pharmacological or psychotherapeutic interventions for suicidal thoughts.

Published
February 24, 2021
Journal
Suicide and Life-Threatening Behavior
Authors
Ballard, E. D., Fields, J., Farmer, C. A., Zarate, C. A.

Quick Facts

Papers Indexed
1
h-Index
115
Open Access
No
Publisher
Wiley
Country
United States
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.